Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy by Coralien H. Vink, Jack F.M. Wetzels, Anne-Els van de Logt

Get full text

A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic... by Caroline Duineveld, Nicole C.A.J. van de Kar, Jack F.M. Wetzels

Get full text

Eculizumab in Posttransplant TMA: Unproven Benefit by Romy N. Bouwmeester, Jack F.M. Wetzels, Nicole C.A.J. van de Kar

Get full text

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome by Bartholomeus T. van den Berge, Jitske Jansen, Jack F.M. Wetzels, Bart Smeets, Rutger J. Maas

Get full text

Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerul... by Willemijn L Eppenga, Cornelis Kramers, Hieronymus J Derijks, Michel Wensing, Jack F M Wetzels, Peter A G M De Smet

Get full text

Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study by Caroline Duineveld, Romy N. Bouwmeester, Lambertus P.W.J. van den Heuvel, Nicole C.A.J. van de Kar, Jack F.M. Wetzels

Get full text

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy by Brad H. Rovin, Pierre M. Ronco, Jack F.M. Wetzels, Sharon G. Adler, Isabelle Ayoub, Philippe Zaoui, Seung Hyeok Han, Jaideep S. Dudani, Houston N. Gilbert, Uptal D. Patel, Paul T. Manser, Julia Jauch-Lembach, Nicola Faulhaber, Rainer Boxhammer, Stefan Härtle, Ben Sprangers

Get full text